|
|
Hokkaido University Collection of Scholarly and Academic Papers >
Showing results 1 to 10 of 10
| Type | Author(s) | Title | Other Titles | Citation | Citation(alt) | Issue Date | | article | Kawagishi, Naoki; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Yamada, Ren; Tokuchi, Yoshimasa; Kubo, Akinori; Kitagataya, Takashi; Shigesawa, Taku; Suzuki, Kazuharu; Ohara, Masatsugu; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Kudo, Yusuke; Nishida, Mutsumi; Sakamoto, Naoya | Baseline elevated serum angiopoietin-2 predicts long-term non-regression of liver fibrosis after direct-acting antiviral therapy for hepatitis C | - | Scientific reports | - | 28-Apr-2021 |
| article | Shigesawa, Taku; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Tokuchi, Yoshimasa; Kubo, Akinori; Yamada, Ren; Furuya, Ken; Baba, Masaru; Kitagataya, Takashi; Suzuki, Kazuharu; Ohara, Masatsugu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, Naoya | Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma | - | PLoS ONE | - | 1-Mar-2021 |
| article | Kubo, Akinori; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Tokuchi, Yoshimasa; Kitagataya, Takashi; Ohara, Masatsugu; Yamada, Ren; Shigesawa, Taku; Suzuki, Kazuharu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Ohnishi, Shunsuke; Sakamoto, Naoya | Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRI | - | Cancers | - | Jul-2021 |
| article (author version) | Sakamoto, Tatsuhiko; Saito, Yoshitaka; Kobayashi, Masaki; Yamada, Takehiro; Takekuma, Yoh; Nakai, Masato; Ogawa, Koji; Iseki, Ken; Sugawara, Mitsuru | Effect of palonosetron and dexamethasone administration on the prevention of gastrointestinal symptoms in hepatic arterial chemoembolization with epirubicin | - | Supportive care in cancer | - | Jul-2020 |
| article (author version) | Suda, Goki; Kudo, Mineo; Nagasaka, Atsushi; Furuya, Ken; Yamamoto, Yoshiya; Kobayashi, Tomoe; Shinada, Keisuke; Tateyama, Miki; Konno, Jun; Tsukuda, Yoko; Yamasaki, Kazushi; Kimura, Megumi; Umemura, Machiko; Izumi, Takaaki; Tsunematsu, Seiji; Sato, Fumiyuki; Terashita, Katsumi; Nakai, Masato; Horimoto, Hiromasa; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, Naoya | Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C | - | Journal of gastroenterology | - | Jul-2016 |
| article | Yoshida, Sonoe; Suda, Goki; Ohara, Masatsugu; Fu, Qingjie; Yang, Zijian; Hosoda, Shunichi; Kimura, Megumi; Akinori, Kubo; Tokuchi, Yoshimasa; Yamada, Ren; Kitagataya, Takashi; Suzuki, Kazuharu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Maehara, Osamu; Ohnishi, Shunsuke; Sakamoto, Naoya | Frequency and Characteristics of Overestimated Renal Function in Japanese Patients with Chronic Liver Disease and Its Relation to Sarcopenia | - | Nutrients | - | Jul-2021 |
| article (author version) | Nakai, Masato; Ogawa, Koji; Takeda, Rei; Ohara, Masatsugu; Kawagishi, Naoki; Izumi, Takaaki; Umemura, Machiko; Ito, Jun; Sho, Takuya; Suda, Goki; Morikawa, Kenichi; Sakamoto, Naoya | Increased serum C-reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis | Predictive factors of tolvaptan efficacy for LC | Hepatology Research | - | Feb-2018 |
| article | Ohara, Masatsugu; Ogawa, Koji; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Shimazaki, Tomoe; Suzuki, Kazuharu; Nakamura, Akihisa; Umemura, Machiko; Izumi, Takaaki; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ohnishi, Shunsuke; Sakamoto, Naoya | L-Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis | - | Hepatology communications | - | Aug-2018 |
| article | Sho, Takuya; Nakanishi, Mitsuru; Morikawa, Kenichi; Ohara, Masatsugu; Kawagishi, Naoki; Izumi, Takaaki; Umemura, Machiko; Ito, Jun; Nakai, Masato; Suda, Goki; Ogawa, Koji; Chuma, Makoto; Meguro, Takashi; Nakamura, Michio; Nagasaka, Atsushi; Horimoto, Hiromasa; Yamamoto, Yoshiya; Sakamoto, Naoya | A Phase I Study of Combination Therapy with Sorafenib and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma | - | Drugs in R&D | - | Sep-2017 |
| article (author version) | Kitagataya, Takashi; Suda, Goki; Nagashima, Kazunori; Katsurada, Takehiko; Yamamoto, Koji; Kimura, Megumi; Maehara, Osamu; Yamada, Ren; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Ohnishi, Shunsuke; Komatsu, Yoshito; Hata, Hiroo; Takeuchi, Satoshi; Abe, Takashige; Sakakibara-Konishi, Jun; Teshima, Takanori; Homma, Akihiro; Sakamoto, Naoya | Prevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy-associated hepatitis in Japan | - | Journal of gastroenterology and hepatology | - | Oct-2020 |
Showing results 1 to 10 of 10
|
